Kuros Biosciences AG (SWX:KURN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
22.82
+0.32 (1.42%)
Aug 4, 2026, 2:12 PM CET

Kuros Biosciences AG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
19.7719.7616.8926.0331.4
Cash & Short-Term Investments
19.7719.7616.8926.0331.4
Cash Growth
0.03%16.98%-35.09%-17.09%-0.66%
Accounts Receivable
30.2114.697.623.051.85
Other Receivables
9.983.011.430.870.39
Total Trade Receivables
40.217.79.063.912.25
Inventory
21.3510.365.773.431.93
Other Current Assets
1.351.260.610.580.51
Total Current Assets
82.6749.0832.3433.9636.08
Net Property, Plant & Equipment
4.683.323.142.512.68
Other Intangible Assets
16.5916.4419.632124.8
Goodwill
24.321.3129.131.7136.62
Other Long-Term Assets
5.642.560.770.55-
Total Assets
133.8892.784.9889.72100.18
Accounts Payable
13.817.581.551.410.93
Accrued Expenses
27.1814.769.435.363.76
Current Portion of Leases
0.650.580.690.450.35
Other Current Liabilities
0.5--6.47.35
Total Current Liabilities
42.1422.9211.6713.6212.38
Long-Term Leases
0.741.391.861.622.01
Other Long-Term Liabilities
6.523.984.01-1.36
Total Long-Term Liabilities
7.255.365.871.623.37
Total Liabilities
49.3928.2817.5415.2415.75
Common Stock
3.233.074.373.953.6
Treasury Stock
---0.02-0.02-0.02
Additional Paid-in Capital
66.8764.8487.18173.23169.56
Accumulated Other Comprehensive Income
31.7627.5626.4423.0622.25
Retained Earnings
-17.38-31.05-50.53-125.74-110.96
Shareholders' Equity
84.4864.4267.4374.4884.43
Total Liabilities & Equity
133.8892.784.9889.72100.18
Total Debt
1.391.972.552.072.35
Net Cash (Debt)
18.3817.814.3523.9629.04
Net Cash Growth
3.28%24.05%-40.13%-17.50%0.15%
Net Cash Per Share
0.440.480.390.710.89
Book Value
84.4864.4267.4374.4884.43
Book Value Per Share
2.041.731.842.202.57
Tangible Book Value
43.5926.6718.7121.7823.01
Tangible Book Value Per Share
1.050.720.510.640.70